Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Recurrent Squamous Cell Lung Carcinoma 1Neoplasm Metastasis 1

Interventions

durvalumab 2Immunoglobulin G 2Docetaxel 2Disulfides 2tremelimumab 1telisotuzumab vedotin 1selinexor 1Nivolumab 1Ipilimumab 1CTLA-4 Antigen 12-(3-(2-(1-isopropyl-3-methyl-1H-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Recurrent Squamous Cell Lung Carcinoma × telisotuzumab vedotin × Clear all
NCT03574753 2021-10-18

Lung-MAP S1400K: c-MET Positive

SWOG Cancer Research Network

Phase 2 Completed
28 enrolled 18 charts

Recurrent Squamous Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡